Home › Funds › Capital Research Global Investors › MO

Capital Research Global Investors position in MO

ALTRIA GROUP INC · Health Care

Capital Research Global Investors reported holding 58,387,121 shares of MO (ALTRIA GROUP INC) in its Q3 2026 13F filing — a position valued at US$3.93B, representing 0.57% of its reported portfolio and ranking #43 among its reported holdings. Capital Research Global Investors has disclosed MO holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)58.39M sh
Reported value held$3.93B
Portfolio Weight0.57%
First reportedQ3 2021
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital Research Global Investors's MO position evolved

Capital Research Global Investors first disclosed a stake in MO in Q3 2021 at 20,932,926 shares (US$952.9M). The position peaked in Q2 2026 at 58,653,624 shares, worth US$4.22B. Across 21 filings, Capital Research Global Investors increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 58,387,121 shares valued at US$3.93B. Notable position changes include a 71% increase in Q4 2022 (shares fell 2% over the following quarter), a 111% increase in Q1 2026 (shares rose 9% over the following quarter), a 128% increase in Q2 2026 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 20.93M $952.88M New
Q4 2021 19.06M $903.17M Reduce
Q1 2022 18.20M $951.20M Reduce
Q2 2022 19.67M $821.53M Add
Q3 2022 20.63M $833.10M Add
Q4 2022 35.35M $1.62B Add
Q1 2023 38.66M $1.72B Add
Q2 2023 34.64M $1.57B Reduce
Q3 2023 13.04M $548.22M Reduce
Q4 2023 13.28M $535.70M Add
Q1 2024 12.04M $525.40M Reduce
Q2 2024 12.04M $548.52M Hold
Q3 2024 12.04M $614.48M Hold
Q4 2024 12.05M $630.18M Hold
Q1 2025 12.08M $724.74M Hold
Q2 2025 12.08M $708.48M Hold
Q3 2025 12.13M $801.41M Hold
Q4 2025 12.15M $700.46M Hold
Q1 2026 25.68M $1.69B Add
Q2 2026 58.65M $4.22B Add
Q3 2026 58.39M $3.93B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MO and 13F data

MO (ALTRIA GROUP INC) is a Health Care company. 23 other funds we track also report a position in MO — the largest reported positions include CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$4.25B), Charles Schwab Investment Management (US$4.25B), Capital Research Global Investors (US$3.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MO

All MO fund holders →

FAQ

How long has Capital Research Global Investors held MO?

Capital Research Global Investors has disclosed MO holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Capital Research Global Investors's current position in MO?

As of Q3 2026, Capital Research Global Investors holds 58.39M shares of MO (ALTRIA GROUP INC), valued at $3.93B, representing 0.57% of its reported portfolio and ranking #43.

Has Capital Research Global Investors been buying or selling MO?

In the latest 13F filing (Q3 2026), Capital Research Global Investors held unchanged its position in MO. The position peaked in Q2 2026 at 58.65M shares.

Which other funds hold MO?

Other major institutional holders of MO include CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, Capital Research Global Investors, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.